Holen Sie sich die Stockscreener-App
16.44
2.32%
-0.4411
Schlusskurs vom Vortag:
$16.88
Offen:
$16.76
24-Stunden-Volumen:
155.29K
Relative Volume:
0.42
Marktkapitalisierung:
$766.43M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
32.88
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
-5.89%
1M Leistung:
-15.92%
6M Leistung:
+32.12%
1J Leistung:
+19.39%
1-Tages-Spanne:
$16.35
$16.92
1-Wochen-Bereich:
$16.35
$18.00
52-Wochen-Spanne:
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, TS, FTI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
16.46 | 785.99M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Slb Ltd
|
48.03 | 72.64B | 35.69B | 3.45B | 4.54B | 2.3617 |
|
BKR
Baker Hughes Company
|
61.02 | 61.80B | 27.73B | 2.62B | 2.54B | 2.605 |
|
HAL
Halliburton Co
|
34.36 | 29.53B | 22.18B | 1.29B | 1.67B | 1.5088 |
|
TS
Tenaris S A Adr
|
53.42 | 26.73B | 11.84B | 2.03B | 1.68B | 3.7282 |
|
FTI
Technipfmc Plc
|
65.88 | 26.45B | 9.93B | 967.10M | 1.45B | 2.3076 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Core Laboratories Delays 2025 Annual 10-K Filing - TipRanks
Core Laboratories (CLB) delays 2025 10-K amid international tax, control review - Stock Titan
CLB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Q1 EPS Forecast for Core Laboratories Lifted by Analyst - Defense World
CLB (Core Laboratories) ROC % : 5.95% (As of Dec. 2025) - GuruFocus
Core Laboratories (NYSE:CLB) Shares Surge Past Key Trend Line Nyse Composite Today - Kalkine Media
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Is Core Laboratories Inc. stock worth buying before Fed action2025 Retail Activity & Low Risk High Win Rate Stock Picks - mfd.ru
CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2024 EARNIN - GuruFocus
Core Labs Jumps 79% in 6 Months: Time to Buy or Stay on the Sidelines? - Finviz
Core Laboratories (CLB) grants 7,526 performance share units to CAO Teo Sow Hang - Stock Titan
Disciplined Growth Investors boosts Core Laboratories (CLB) stake to 11.1% - Stock Titan
Is Core Laboratories Inc. stock safe for risk averse investorsJuly 2025 Action & Free High Accuracy Swing Entry Alerts - mfd.ru
Will Core Laboratories Inc. stock recover faster than peersJuly 2025 Macro Moves & Verified Momentum Stock Ideas - mfd.ru
Core Laboratories (NYSE:CLB) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Will Core Laboratories Inc. stock keep outperforming rivalsM&A Rumor & Short-Term Swing Trade Alerts - mfd.ru
Core Laboratories : Lab Celebrates 90 Years of Innovation, Insights & Impact - marketscreener.com
Can Core Laboratories Inc stock outperform in a bear marketTrade Ideas & Long-Term Capital Growth Ideas - baoquankhu1.vn
Core Laboratories Inc.: - marketscreener.com
Can Core Laboratories Inc. benefit from deglobalizationJuly 2025 Summary & Free Real-Time Volume Trigger Notifications - mfd.ru
Core Laboratories Q4 Earnings Call Highlights - Defense World
Core Laboratories outlines Q1 2026 guidance of $124M–$130M revenue amid strong international demand and cost challenges - MSN
Core Laboratories N.V. (NYSE:CLB) Q4 2025 Earnings Call Transcript - Insider Monkey
Core Laboratories Q4 Earnings Beat Estimates, Expenses Increase Y/Y - TradingView
Core Laboratories to Announce Q4 Earnings on February 4 - Intellectia AI
Core Laboratories Stock Under Pressure: Is This Energy Services Veteran a Contrarian Buy or a Value - AD HOC NEWS
Core Laboratories (NYSE:CLB) Shares Down 12%Here's Why - MarketBeat
Core Lab (CLB) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Core Laboratories Q4 2025 earnings miss forecasts By Investing.com - Investing.com Canada
Core Laboratories Inc. (NYSE:CLB) Declares Quarterly Dividend of $0.01 - MarketBeat
Core Laboratories Stock Finds Its Footing: Modest Rebound Amid Cautious Energy Sentiment - AD HOC NEWS
Core Laboratories (CLB) Anticipates Q1 Revenue Between $124M and $130M - GuruFocus
Core Laboratories (CLB) Exceeds Revenue Expectations in Q4, Boos - GuruFocus
Core Laboratories (NYSE:CLB) Announces Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Core Laboratories: Fourth Quarter Earnings Overview - Bitget
Core Laboratories: Q4 Earnings Snapshot - KTEN
Core Laboratories (NYSE:CLB) Releases Q1 2026 Earnings Guidance - MarketBeat
Core Laboratories expects Q1 rev between $124 mln to $130 mln - marketscreener.com
Core Laboratories posts Q4 2025 results and dividend - TipRanks
(CLB) Core Laboratories Inc. Expects Q1 Revenue Range $124.0M$130.0M - marketscreener.com
Earnings Flash (CLB) Core Laboratories Inc. Reports Q4 Revenue $138.3M, vs. FactSet Est of $132.1M - marketscreener.com
Earnings Flash (CLB) Core Laboratories Inc. Posts Q4 Adjusted EPS $0.21 per Share, vs. FactSet Est of $0.19 - marketscreener.com
CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - PR Newswire
Quarterly Earnings: Is Core Laboratories Inc. stock positioned for digital transformation2025 Price Targets & Long-Term Growth Stock Strategies - mfd.ru
Investors in Core Laboratories (NYSE:CLB) have unfortunately lost 47% over the last five years - Yahoo Finance
What's in Store for Core Laboratories Stock in Q4 Earnings? - Yahoo Finance
Is Core Laboratories Inc.'s (NYSE:CLB) Latest Stock Performance A Reflection Of Its Financial Health? - 富途牛牛
Core Laboratories (CLB) Expected to Announce Earnings on Wednesday - MarketBeat
EPS Watch: Can Core Laboratories Inc be the next market leaderMarket Volume Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):